LHCVX Holdings Information

LHCVX is a mutual fund with a total of 57 individual holdings. The top holdings are Eli Lilly and Company stock at 9.68%, Gilead Sciences at 4.52%, AstraZeneca at 4.14%, argenx SE at 4.08%, and Guardant Health at 3.38%.

Total Holdings

Top 10 Percentage

40.51%

Asset Class

Equity

Fund Category

Health

Assets

8.61M

Forward PE Ratio

25.46

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	9.68%	775
2	GILD	Gilead Sciences, Inc.	4.52%	2,647
3	LON: AZN	AstraZeneca PLC	4.14%	1,846
4	EBR: ARGX	argenx SE	4.08%	406
5	GH	Guardant Health, Inc.	3.38%	2,459
6	NTRA	Natera, Inc.	3.20%	1,151
7	TMO	Thermo Fisher Scientific Inc.	2.98%	428
8	COR	Cencora, Inc.	2.95%	681
9	TARS	Tarsus Pharmaceuticals, Inc.	2.81%	3,622
10	ISRG	Intuitive Surgical, Inc.	2.77%	457
11	EPA: EL	EssilorLuxottica Société anonyme	2.51%	681
12	COGT	Cogent Biosciences, Inc.	2.15%	4,983
13	BBIO	BridgeBio Pharma, Inc.	2.12%	2,278
14	TERN	Terns Pharmaceuticals, Inc.	2.12%	5,083
15	CVS	CVS Health Corporation	2.08%	2,320
16	MDGL	Madrigal Pharmaceuticals, Inc.	2.06%	350
17	MIRM	Mirum Pharmaceuticals, Inc.	2.05%	1,651
18	EBR: UCB	UCB SA	1.90%	522
19	ASND	Ascendis Pharma A/S	1.90%	698
20	SWX: GALD	Galderma Group AG	1.83%	818
21	JNJ	Johnson & Johnson	1.74%	635
22	ABVX	ABIVAX Société Anonyme	1.73%	1,296
23	IDXX	IDEXX Laboratories, Inc.	1.69%	209
24	BSX	Boston Scientific Corporation	1.58%	1,400
25	CELC	Celcuity Inc.	1.54%	1,169

Showing 25 of 57 holdings

Subscribe to see the full list

Activate Now

As of Jan 31, 2026